BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lucero LM, Weltzin MM, Eaton JB, et al. (2015) Differential α4(+)/(-)β2 Agonist Binding Site Contributions to α4β2 Nicotinic Acetylcholine Receptor Function Within and Between Isoforms. The Journal of Biological Chemistry
Weltzin MM, Lindstrom JM, Lukas RJ, et al. (2015) Distinctive effects of nicotinic receptor intracellular-loop mutations associated with nocturnal frontal lobe epilepsy. Neuropharmacology
Zhang Q, Du Y, Zhang J, et al. (2015) Functional Impact of 14 Single Nucleotide Polymorphisms Causing Missense Mutations of Human α7 Nicotinic Receptor. Plos One. 10: e0137588
Mulcahy MJ, Blattman SB, Barrantes FJ, et al. (2015) Resistance to Inhibitors of Cholinesterase 3 (Ric-3) Expression Promotes Selective Protein Associations with the Human α7-Nicotinic Acetylcholine Receptor Interactome. Plos One. 10: e0134409
Liu Q, Kuo YP, Shen J, et al. (2015) Roles of nicotinic acetylcholine receptor β subunit cytoplasmic loops in acute desensitization and single-channel features. Neuroscience. 289: 315-23
Yu LF, Brek Eaton J, Zhang HK, et al. (2014) The potent and selective α4β2*/α6*-nicotinic acetylcholine receptor partial agonist 2-[5-[5-((S)Azetidin-2-ylmethoxy)-3-pyridinyl]-3-isoxazolyl]ethanol demonstrates antidepressive-like behavior in animal models and a favorable ADME-tox profile. Pharmacology Research & Perspectives. 2: e00026
Onajole OK, Eaton JB, Lukas RJ, et al. (2014) Enantiopure Cyclopropane-Bearing Pyridyldiazabicyclo[3.3.0]octanes as Selective α4β2-nAChR Ligands. Acs Medicinal Chemistry Letters. 5: 1196-201
Moretti M, Zoli M, George AA, et al. (2014) The novel α7β2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization. Molecular Pharmacology. 86: 306-17
Yu LF, Zhang HK, Caldarone BJ, et al. (2014) Recent developments in novel antidepressants targeting α4β2-nicotinic acetylcholine receptors. Journal of Medicinal Chemistry. 57: 8204-23
Carroll FI, Blough BE, Mascarella SW, et al. (2014) Bupropion and bupropion analogs as treatments for CNS disorders. Advances in Pharmacology (San Diego, Calif.). 69: 177-216
See more...